These regulatory mechanisms shed light on the complex regulation of FSP1 in cancer, highlighting the involvement of NRF2, KEAP1, and NAT10 in modulating FSP1 expression and activity in the context of ferroptosis and therapeutic responses. The gene discussed is NAT10; the disease is cancer.